Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?

Journal of Nephrology

Volumn 29, Issue 5, 2016, Pages 627-636

  Nerini, Erika ^a   Bruno, Fulvio ^a   Citterio, Franco ^b   Schena, Francesco P ^c  

^a FBCommunication   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Immunosuppressive therapy; Interactive voice response system; Kidney transplantation; Nonadherence

Indexed keywords

CAREGIVER SUPPORT; CHRONIC GRAFT REJECTION; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; END STAGE RENAL DISEASE; GRAFT FAILURE; HEALTH CARE COST; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KNOWLEDGE; OUTCOME ASSESSMENT; PSYCHOLOGIC ASSESSMENT; REVIEW; SOCIAL SUPPORT; TREATMENT REFUSAL; WORLD HEALTH ORGANIZATION; ADVERSE EFFECTS; ATTITUDE TO HEALTH; DEVICES; DRUG EFFECTS; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MEDICATION COMPLIANCE; MOBILE APPLICATION; MOBILE PHONE; MORTALITY; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY; REMINDER SYSTEM; RISK FACTOR; TELEMEDICINE; TREATMENT OUTCOME;

IMMUNOSUPPRESSIVE AGENT;

CELL PHONES; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MEDICATION ADHERENCE; MOBILE APPLICATIONS; PATIENT EDUCATION AS TOPIC; REMINDER SYSTEMS; RISK FACTORS; TELEMEDICINE; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84987740565     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-016-0273-x     Document Type: Review

References (86)

1. European Commission (2012) Organ donation and transplantation: an invitation of the European Commission. Facts & figures. http://ec.europa.eu/health. Accessed 2 July 2014
2. Sabaté E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
3. Masand PS, Roca M, Turner MS, Kane JM (2009) Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 11:147–154
4. Chakrabarti S (2014) What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry 4:30–36
5. Shemesh E, Annunziato RA, Arnon R et al (2010) Adherence to medical recommendations and transition to adult services in pediatric transplant recipients. Curr Opin Organ Transpl 15:288–292
6. Denhaerynck K, Dobbels F, Cleemput I et al (2005) Prevalence, consequences, and determinants of non-adherence in adult renal transplant patients: a literature review. Transpl Int 18:1121–1133
7. Prendergast MB, Gaston RS (2010) Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol 5:1305–1311
8. Center for Disease Control and Prevention (2015) Self-study modules on tuberculosis. Module 9: patient adherence to tuberculosis treatment reading material. http://www.cdc.gov/tb/education/ssmodules/module9/ss9reading2.htm Accessed 30 Oct 2015
9. Karumbi J, Garner P (2015) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 29:1–56
10. de Castilla DL, Rakita RM, Spitters CE, Narita M, Jain R, Limaye AP (2014) Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates. Transplantation 97:206–211
11. Subramanian AK, Morris MI, AST Infectious Diseases Community of Practice (2013) Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 13:68–76
12. Dunbar-Jacob J, Sereika S, Rohay JM, Burke LE (1998) Electronic methods in assessing adherence to medical regimens. In: Krantz D, Baum A (eds) Technology and methods in behavioral medicine. Lawrence Erlbaum Associates, Mahwah, pp 95–113
13. Liu H, Golin CE, Miller LG et al (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134:968
14. Schafer-Keller P, Steiger J, Bock A et al (2008) Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 8:616–626
15. Denhaerynck K, Steiger J, Bock A et al (2007) Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 7:108–116
16. van den Boogaard Lyimo RA, Boeree M, Kibiki GS, Aarnoutse RE (2011) Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ 89:632–639
17. Denhaerynck K, Schmid-Mohler G, Kiss A et al (2014) Differences in medication adherence between living and deceased donor kidney transplant patients. Int J Organ Transplant Med 5:7–14
18. Burra P, Germani G, Gnoato F et al (2011) Adherence in liver transplant recipients. Liver Transpl 17:760–770
19. Building a better world for our transplant patients. In: Joint 3rd European Symposium of the International Transplant Nurses Society (ITNS) and the 5th congress of the italian society for safety and quality in transplantation (SISQT), Florence, Italy, 8–12 Apr 2013
20. Dew MA, DiMartini AF, Dabbas De Vito et al (2007) Rates and risk factors for nonadherence to the medical regimen after adult solid transplantation. Transplantation 83:858–873
21. Germani G, Lazzaro S, Gnoato F et al (2011) Nonadherent behaviors after solid organ transplantation. Transplant Proc 43:318–323
22. Massey EK, Tielen M, Langing M et al (2013) The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. J Psychosom Res 75:229–234
23. Schmid-Mohler G, Thut MP, Wüthrich RP et al (2010) Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin Transplant 24:213–222
24. Denhaerynck K, Desmyttere A, Dobbels F et al (2006) Non-adherence with immunosuppressive drugs: U.S. compared with European kidney transplant recipients. Prog Transplant 16:206–214
25. Griva K, Davenport A, Harrison M, Newman SP (2012) Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medical intake. Ann Behav Med 44:85–93
26. Weng FL, Chandwani S, Kurtyka KM et al (2013) Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. BMC Nephrol 14:261–270
27. Butler J, Peveler RC, Roderick P et al (2004) Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 19:3144–3149
28. Weng FL, Israni A, Joffe M et al (2005) Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 16:1839–1848
29. Kalil RS, Heim-Duthoy KL, Kasiske BL (1992) Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 20:63–69
30. Sketris I, Waite N, Grobler K et al (1994) Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc 26:2538–2541
31. Gaynor JJ, Ciancio G, Guerra G et al (2014) Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study. Transplantation 97:925–933
32. Lurie S, Shemesh E, Sheiner P et al (2000) Non-adherence in pediatric liver transplant recipients—an assessment of risk factors and natural history. Pediatr Transplant 4:200–206
33. Chisholm-Burns MA, Spivey C, Rehfeld R et al (2009) Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 9:2497–2504
34. Pinsky BW, Takemoto SK, Lentine KL et al (2009) Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 9:2597–2606
35. John U, Offner G, Breuch K, Oldhafer M (2009) Concept to improve adherence in adolescent following renal transplantation: vision or reality? Urologe 48:1468–1472
36. Rianthavorn P, Ettenger RB, Melekzadeh M et al (2004) Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplant. Transplantation 77:778–782
37. Rianthavorn P, Ettenger RB (2005) Medical non-adherence in the adolescent renal transplant recipients: a clinician’s viewpoint. Pediatr Transplant 9:398–407
38. Bullington P, Pawola L, Walker R et al (2007) Identification of medication non-adherence factors in adolescent transplant patients: the patient’s viewpoint. Pediatr Transplant 11:914–921
39. Zelikovsky N, Schast AP, Palmer J, Meyers KE (2008) Perceived barriers to adherence among adolescent renal transplant candidates. Pediatr Transplant 12:300–308
40. Vasquez EM, Tanzi M, Benedetti E, Pollak R (2003) Medication noncompliance after kidney transplantation. Am J Health Syst Pharm 60:266–269
41. Evans RW, Applegate WH, Briscoe DM et al (2010) Cost-related immunosuppressive medication non-adherence among kidney transplant recipients. Clin J Am Soc Nephrol 5:2323–2328
42. Woodward RS, Schnitzler MA, Lowell JA et al (2001) Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal tranplants. Am J Transplant 1:69–73
43. Tanriover B, Stone PW, Mohnan S, Cohen DJ, Gaston RS (2013) Future of medicare immunosuppressive drug coverage for kidney transplant recipients in the United States. Clin J Am Soc Nephrol 8:1258–1266
44. Gill JS, Tonelli M (2012) Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation. N Engl J Med 366:586–589
45. Butler JA, Roderick P, Mullee M et al (2004) Frequency and impact of non-adherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 77:769–776
46. Didlake RH, Dreyfus K, Kerman RH et al (1988) Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 20:63–68
47. Sellarés J, de Freitas DG, Mengel M et al (2012) Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 12:388–399
48. Prihodova L, Nagyova I, Rosenberger J et al (2014) Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study. J Adv Nurs 70:2871–2883
49. Hansen R, Seifeldin R, Noe L (2007) Medication adherence in chronic disease: issues in posttransplant immunosuppression. Transplant Proc 39:1287–1300
50. De Bleser L, Matteson M, Dobbels F et al (2009) Interventions to improve medication-adherence after transplantation: a systematic review. Transplant Int 22:780–797
51. Kripalani S, Yao X, Haynes RB (2007) Interventions to enhance medication adherence in chronic conditions: a systematic review. Arch Intern Med 167:540–550
52. Gordon EJ, Gallant M, Sehgal AR et al (2009) Medication-taking among adult transplant recipients: barriers and strategies. Transplant Int 22:534–545
53. Medication adherence in kidney transplant recipients using automated reminders and provider notification. http://clinicaltrials.gov/show/NCT01541384: NLM Identifier NCT01541384. Accessed 2 July 2014
54. Kuypers DR, Peeters PC, Sennesael JJ et al (2013) Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation 95:333–340
55. Low JK, Williams A, Manias E, Crawford K (2015) Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrol Dial Transplant 30:752–761
56. World Health Organization (2015) E-health. trade, foreign policy, diplomacy and health. http://www.who.int/trade/glossary/story021/en/. Accessed 30 Oct 2015
57. Rinfret S, Rodés-Cabau J, Bagur R et al (2013) Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation. Heart 99:562–569
58. Zurovac D, Sudoi RK, Akhwale WS et al (2011) The effect of mobile phone text-message reminders on kenyan health workers’ adherence to malaria treatment guidelines: a cluster randomised trial. Lancet 378: 795–803
59. Stockwell MS, Kharbanda EO, Martinez RA et al (2012) Effect of a text messaging intervention on influenza vaccination in a urban, low-income pediatric and adolescent population: a randomized controlled trial. JAMA 307:1702–1708
60. Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS (2014) Electronic medication packaging devices and medication adherence: a systematic review. JAMA 312:1237–1247
61. Ingerski LM, Hente EA, Modi AC, Hommel KA (2011) Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. J Pediatr 159:528–534
62. Granger BB, Bosworth H (2011) Medication adherence: emerging use of technology. Curr Opin Cardiol 26:279–287
63. Friedman RH, Kazis LE, Jette A et al (1996) A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 9:285–292
64. Piette JD, Weinberger M, Kraemer FB, McPhee SJ (2001) Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care 24:202–208
65. Raebel MA, Charles J, Dugan J et al (2007) Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc 55:977–985
66. Wald DS, Bestwick JP, Raiman L et al (2014) Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT Trial). PLoS One 9:e114268
67. Vollmer WM, Feldstein A, Smith DH et al (2011) Use of health information technology to improve medication adherence. Am J Manag Care 17:SP79–SP87
68. Bender BG, Apter A, Bogen DK et al (2010) Test of an interactive voice response intervention to improve adherence controller medications in adult with asthma. J Am Board Fam Med 23:159–165
69. Piette JD, Marinec N, Gallegos-Cabriales EC et al (2013) Spanish-speaking patients’ engagement in interactive voice response (IVR) support calls for chronic disease self-management: data from three countries. J Telemed Telecare 19:89–94
70. Rodrigues R, Shet A, Antony J et al (2012) Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One 7:e40723
71. World Health Organization (2005) 58th World Health Assembly, Geneva, Switzerland. http://www.who.int/ehealth/about/en/. Accessed 2 July 2014
72. Stefanelli C, Nerini E (2012) IVRS in the service of patient adherence. J Patient Compliance 2:28–29
73. Bosworth HB (2012) How can innovative uses of technology be harnessed to improve medication adherence? Expert Rev Pharmacoecon Outcomes Res 12:133–135
74. Dayer L, Heldenbrand S, Anderson P et al (2013) Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc 53:172–181
75. Miloh T, Annunziato R, Arnon R et al (2009) Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 124:e844–e850
76. McGillicuddy JW, Weiland AK, Frenzel RM et al (2013) Patient attitudes towards mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res 15:e6
77. McGillicuddy JW, Gregoski MJ, Weiland A et al (2013) Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Res Protoc 2:e32
78. Fredericks EM, Dore-Stites D (2010) Adherence to immunosuppressants: how can it be improved in adolescent organ transplant recipients? Curr Opin Organ Transplant 15:614–620
79. Akchurin OM, Hollmann AP, Sears D et al (2014) Utilization of smart phones and medication adherence in adolescents with kidney disorders. J Am Soc Nephrol 25:463A
80. Aikens JE, Trivedi R, Aron DC, PIette JD (2015) Integrating support person into diabetes telemonitoring to improve self-management and medication adherence. J Gen Intern Med 30:319–326
81. Aikens JE, Rosland AM, Piette JD (2014) Improvements in illness self-management and psychological distress associated with telemonitoring support for adults with diabetes. Prim Care Diabetes 9:127–134
82. Haberer JE, Kiwanuka J, Nansera D et al (2013) Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS 27:2166–2168
83. Tucker JA, Simpson CA, Huang J et al (2013) Utility of an interactive voice response system to access antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South. AIDS Patient Care STDS 27:280–286
84. Nerini E, Grip L, Camm AJ, Giugliano RP (2013) Atrial fibrillation and the ‘other drug problem’: reducing non-adherence with technology. Eur Heart J 34:2031–2033
85. Blasi F, Raddi F, Miravitlles M (2015) Interactive monitoring service and COPD: is it possible to reduce non-adherence? COPD 12:227–232
86. Roebuck MC, Liberman JN, Gemill-Toyama M, Brennan TA (2011) Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 30:91–99